SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2170090

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2170090

Collagen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

PUBLISHED:
PAGES: 191 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Collagen Market exceeded USD 5.57 billion in 2025 and is projected to grow at 6.2% CAGR to reach USD 10.17 billion by 2035.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$5.57 Billion
Forecast Value$10.17 Billion
CAGR6.2%

Population aging supports continued interest in joint mobility, bone health, skin appearance, and recovery, giving collagen suppliers opportunities across supplements, medical nutrition, and beauty. Manufacturers can address these needs through clinically supported ingredients and dosage formats aligned with specific customers. Stable porcine by-product streams provide another commercial foundation by supporting output continuity and cost-competitive supply for food and capsule uses. Religious and source preferences nevertheless limit where those materials fit, encouraging producers to maintain suitable alternatives. Regulatory recognition of precision-fermentation ingredients adds a separate route to product differentiation. Animal-free options can support brands seeking clear source identity and traceability while retaining functional claims. These drivers connect demand growth with both established processing economics and new sourcing possibilities, favoring suppliers able to maintain consistent quality and provide formulations appropriate to the health, cultural, and application requirements of their intended end markets.

Based on product type, hydrolyzed collagen peptides are projected to reach USD 4.55 billion by 2035. Powders, beverages, capsules, and fortified foods allow brands to incorporate the ingredients into familiar daily routines. This versatility supports positioning around beauty, joints, sports nutrition, and healthy aging, giving the segment several consumer and formulation pathways. Suppliers must connect ingredient performance with formats and claims appropriate to those uses. The commercial opportunity therefore reflects more than one supplement category, while retaining a need for consistent material and suitable customer support. Manufacturers able to address different end-use specifications can participate across brands seeking functional ingredients that fit regular consumption and differentiated wellness offerings.

By source, bovine collagen contributed revenue of USD 1.67 billion for 2025. Its established role in type-I collagen, gelatin, and peptide supply chains provides a broad commercial foundation. Producers must nevertheless manage changing availability, traceability requirements, and buyer interest in other source profiles. Those considerations influence whether familiar material remains suitable for a particular formulation or procurement program. Suppliers with dependable sourcing and documentation can support existing uses while responding to evolving customer requirements. The segment's position consequently combines embedded processing and application knowledge with continuing supply-management needs, making material assurance and alignment with source preferences important to retaining demand across established collagen and gelatin customer channels.

The North America collagen market is projected to reach USD 2.90 billion by 2035. Developed supplement retail and consumer familiarity with beauty, mobility, and sports-nutrition products support demand. Established food and supplement pathways coexist with higher-value medical uses, giving ingredient suppliers access to several commercial environments. Branded platforms can obtain premium positioning where technical support and appropriate evidence align with customer needs. Regional opportunity therefore depends on translating familiar health interests into suitable formulations rather than ingredient availability alone. Companies able to combine consistent supply with application knowledge can serve manufacturers seeking products that fit established distribution channels and differentiated positioning across nutrition, healthcare, and consumer wellness markets.

Rousselot represented 25% of the market during 2025. Its manufacturing reach and ingredient platform support participation in gelatin, peptides, and health-related collagen applications. The company can address established processing demand while commercializing specialized products for wellness and nutrition customers. Its competitive position therefore combines scale with the ability to serve technically differentiated uses. Maintaining that advantage depends on reliable quality and the support required to translate ingredients into customer formulations. Its breadth remains valuable where buyers evaluate both supply continuity and specific application needs, connecting manufacturing capability with product development in markets that increasingly distinguish premium peptide platforms from more conventional gelatin and collagen ingredient purchasing.

Some of the major players in this market are GELITA AG, PB Leiner, Nitta Gelatin, Weishardt, JBS through Genu-in, Italgelatine, Lapi Gelatine, Sterling Gelatin, Titan Biotech, Norland Products, Amicogen, Nippi, CollPlant Biotechnologies, Bioiberica, BioCell Technology, Advanced BioMatrix, and Holista CollTech. Competition spans food ingredients, specialized peptide platforms, medical materials, and regional production. Suppliers differentiate through validation, source portfolios, certifications, and application expertise alongside processing efficiency. Marine and other specialized offerings create further opportunities. The varied competitive field makes customer access and technical support important, with raw-material control and regulatory qualification reinforcing scale advantages while focused providers address demanding uses and specific sourcing requirements.

Product Code: 206

Table of Contents

Chapter 1. Research Methodology

  • 1.1 Research Approach
  • 1.2 Quality Commitments
    • 1.2.1 GMI AI Policy Data Integrity Commitment
      • 1.2.1.1 Source Consistency Protocol
  • 1.3 Research Trail Confidence Scoring
    • 1.3.1 Research Trail Components
    • 1.3.2 Scoring Components
  • 1.4 Data Collection
    • 1.4.1 Partial List of Primary Sources
  • 1.5 Data Mining Sources
    • 1.5.1 Paid Sources
      • 1.5.1.1 Sources, By Region
  • 1.6 Base Estimates Calculations
    • 1.6.1 Base Year Calculation
  • 1.7 Forecast Model
    • 1.7.1 Quantified Market Impact Analysis
      • 1.7.1.1 Mathematical Impact of Growth Parameters on Forecast
  • 1.8 Research Transparency Addendum
    • 1.8.1 Source Attribution Framework
    • 1.8.2 Quality Assurance Metrics
    • 1.8.3 Our Commitment to Trust

Chapter 2. Executive Summary

  • 2.1 Industry 360° Synopsis
  • 2.2 Key Market Trends
    • 2.2.1 Product Type Trends
    • 2.2.2 Source Trends
    • 2.2.3 Application Trends
    • 2.2.4 Regional Trends
  • 2.3 TAM analysis, 2027-2035 (USD Billion)
  • 2.4 CXO Perspectives: Strategic Imperatives

Chapter 3. Industry Insights

  • 3.1 Industry Ecosystem Analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Cost Structure
    • 3.1.4 Value Addition at Each Stage
    • 3.1.5 Factors Affecting the Value Chain
    • 3.1.6 Disruptions
  • 3.2 Industry Impact Forces
    • 3.2.1 Growth Drivers
    • 3.2.2 Industry Pitfalls Challenges
    • 3.2.3 Market Opportunities
  • 3.3 Growth Potential Analysis
  • 3.4 Pricing Analysis (Driven by Primary Research)
    • 3.4.1 Historical Price Trend Analysis (Driven by Primary Research)
    • 3.4.2 Pricing Strategy by Player Type (Premium / Value / Cost-plus) (Driven by Primary Research)
  • 3.5 Regulatory Landscape
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Asia Pacific
    • 3.5.4 Latin America
    • 3.5.5 Middle East Africa
  • 3.6 Porter's Analysis
  • 3.7 PESTEL Analysis
  • 3.8 Trade Data Analysis (Based on Paid Database)
    • 3.8.1 Import/Export Volume Value Trends (Based on Paid Database)
    • 3.8.2 Key Trade Corridors Tariff Impact (Based on Paid Database)
  • 3.9 Impact of AI Generative AI on the Market (Driven by Primary Research)
    • 3.9.1 AI-Driven Disruption of Existing Business Models
    • 3.9.2 GenAI Use Cases Adoption Roadmap by Segment
    • 3.9.3 Risks, Limitations Regulatory Considerations
  • 3.10 Capacity Production Landscape (Driven by Primary Research)
    • 3.10.1 Production Capacity by Region Key Producer (Driven by Primary Research)
    • 3.10.2 Capacity Utilization Rates Expansion Pipelines (Driven by Primary Research)

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company Market Share Analysis
    • 4.2.1 By Region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 Latin America
      • 4.2.1.5 Middle East Africa
    • 4.2.2 Market Concentration Analysis
  • 4.3 Competitive Analysis of Major Market Players
  • 4.4 Competitive Positioning Matrix
  • 4.5 Key Developments
    • 4.5.1 Mergers Acquisitions
    • 4.5.2 Partnerships Collaborations
    • 4.5.3 New Product Launches
    • 4.5.4 Expansion Plans Funding
  • 4.6 Company Tier Benchmarking
    • 4.6.1 Tier Classification Criteria Qualifying Thresholds
    • 4.6.2 Tier Positioning Matrix by Revenue, Geography Innovation

Chapter 5. Collagen Market Estimates Forecast, By Product Type (USD Million, Kilotons, 2022–2035)

  • 5.1 Hydrolyzed Collagen (Collagen Peptides)
    • 5.1.1 Bovine-Derived Hydrolyzed Collagen
    • 5.1.2 Marine-Derived Hydrolyzed Collagen
    • 5.1.3 Porcine-Derived Hydrolyzed Collagen
    • 5.1.4 Poultry-Derived Hydrolyzed Collagen
  • 5.2 Gelatin
    • 5.2.1 Type A Gelatin (Acid-Processed / Porcine-Derived)
    • 5.2.2 Type B Gelatin (Alkali-Processed / Bovine-Derived)
  • 5.3 Native Collagen
    • 5.3.1 Type I Native Collagen
    • 5.3.2 Type II Native Collagen
    • 5.3.3 Type III Native Collagen
  • 5.4 Others (Recombinant/Bioengineered Plant-Based Collagen Boosters)

Chapter 6. Collagen Market Estimates Forecast, By Source (USD Million, Kilotons, 2022–2035)

  • 6.1 Bovine
    • 6.1.1 Bovine Hide-Derived
    • 6.1.2 Bovine Bone-Derived
  • 6.2 Porcine
  • 6.3 Poultry
    • 6.3.1 Chicken Feet-Derived
    • 6.3.2 Chicken Sternal Cartilage-Derived
  • 6.4 Marine
    • 6.4.1 Fish Skin Scale-Derived
    • 6.4.2 Jellyfish Other Marine Organisms-Derived
  • 6.5 Plant-Based Others (Collagen Boosters, Recombinant)

Chapter 7. Collagen Market Estimates Forecast, By Application (USD Million, Kilotons, 2022–2035)

  • 7.1 Food Beverages
    • 7.1.1 Functional Beverages Bone Broth
    • 7.1.2 Confectionery (Gummies, Jellies, Marshmallows)
    • 7.1.3 Dairy Products
    • 7.1.4 Snacks, Soups Sauces
    • 7.1.5 Pet Food Animal Nutrition
    • 7.1.6 Others
  • 7.2 Cosmetics Personal Care
    • 7.2.1 Anti-Aging Skin Care (Creams, Serums, Masks)
    • 7.2.2 Hair Care
    • 7.2.3 Oral Care
    • 7.2.4 Body Care Others
  • 7.3 Healthcare Pharmaceuticals
    • 7.3.1 Wound Care (Dressings, Hemostats)
    • 7.3.2 Orthobiologics (Bone Grafts, Cartilage Repair, Joint Reconstruction)
    • 7.3.3 Drug Delivery Systems Capsule Shells
    • 7.3.4 Dental Applications
    • 7.3.5 Cardiovascular Surgical Applications
    • 7.3.6 Tissue Engineering Regenerative Medicine
  • 7.4 Nutraceuticals Dietary Supplements
    • 7.4.1 Capsules Tablets
    • 7.4.2 Powder Supplements
    • 7.4.3 Gummies Soft Chews
    • 7.4.4 Ready-to-Drink (RTD) Supplement Beverages
  • 7.5 Others (Textile, Industrial, Photography)

Chapter 8. Collagen Market Estimates Forecast, By Region (USD Million, Kilotons, 2022–2035)

  • 8.1 Key Trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 India
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East & Africa

Chapter 9. Company Profiles (Driven by Primary Research)

  • 9.1 Rousselot
  • 9.2 GELITA AG
  • 9.3 Tessenderlo Group
  • 9.4 Nitta Gelatin Inc.
  • 9.5 Weishardt Group
  • 9.6 JBS S.A. (via Genu-in)
  • 9.7 Italgelatine S.p.A.
  • 9.8 Sterling Gelatin
  • 9.9 Norland Products Inc.
  • 9.10 Titan Biotech Ltd.
  • 9.11 Lapi Gelatine S.p.A.
  • 9.12 Amicogen Inc.
  • 9.13 Nippi Inc.
  • 9.14 CollPlant Biotechnologies Ltd.
  • 9.15 Bioiberica S.A.U.
  • 9.16 BioCell Technology LLC
  • 9.17 Advanced BioMatrix Inc.
  • 9.18 Holista CollTech Ltd.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!